Traders' overwhelming consensus (93.5% implied probability) for an 80–85 cumulative influenza hospitalization rate per 100,000 population in Week 13 reflects the latest CDC FluSurv-NET data from the Week 12 FluView report (April 3, 2026), showing 82.7 per 100,000 amid sharply declining activity: weekly rate fell to 0.8 per 100,000, outpatient influenza-like illness (ILI) visits dropped to 2.6% below baseline, and clinical lab positivity declined to 9.8%, dominated by A(H3N2). FluSight ensemble forecasts further reductions in national hospital admissions. This season's rate ranks third highest since 2010–11, but end-of-season trends support stability. Challenges could arise from reporting delays inflating the figure above 85 or an unforeseen late rebound in cases among high-risk groups like those ≥65 years (266.9 per 100,000 cumulative). Week 13 data expected next week.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jourFlu Hospitalization Rate Week 13, 2026?
Flu Hospitalization Rate Week 13, 2026?
80–85 95%
85–90 3.1%
<70 1.9%
90+ 1.5%
NOUVEAU
NOUVEAU
10 avr. 2026
<70
2%
70–75
1%
75–80
1%
80–85
95%
85–90
3%
90+
2%
80–85 95%
85–90 3.1%
<70 1.9%
90+ 1.5%
NOUVEAU
NOUVEAU
10 avr. 2026
<70
$404 Vol.
2%
70–75
$295 Vol.
1%
75–80
$133 Vol.
1%
80–85
$255 Vol.
95%
85–90
$43 Vol.
3%
90+
$772 Vol.
2%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' overwhelming consensus (93.5% implied probability) for an 80–85 cumulative influenza hospitalization rate per 100,000 population in Week 13 reflects the latest CDC FluSurv-NET data from the Week 12 FluView report (April 3, 2026), showing 82.7 per 100,000 amid sharply declining activity: weekly rate fell to 0.8 per 100,000, outpatient influenza-like illness (ILI) visits dropped to 2.6% below baseline, and clinical lab positivity declined to 9.8%, dominated by A(H3N2). FluSight ensemble forecasts further reductions in national hospital admissions. This season's rate ranks third highest since 2010–11, but end-of-season trends support stability. Challenges could arise from reporting delays inflating the figure above 85 or an unforeseen late rebound in cases among high-risk groups like those ≥65 years (266.9 per 100,000 cumulative). Week 13 data expected next week.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Marché ouvert : Apr 3, 2026, 12:08 PM ET
Volume
$1,901Date de fin
10 avr. 2026Marché ouvert
Apr 3, 2026, 12:08 PM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' overwhelming consensus (93.5% implied probability) for an 80–85 cumulative influenza hospitalization rate per 100,000 population in Week 13 reflects the latest CDC FluSurv-NET data from the Week 12 FluView report (April 3, 2026), showing 82.7 per 100,000 amid sharply declining activity: weekly rate fell to 0.8 per 100,000, outpatient influenza-like illness (ILI) visits dropped to 2.6% below baseline, and clinical lab positivity declined to 9.8%, dominated by A(H3N2). FluSight ensemble forecasts further reductions in national hospital admissions. This season's rate ranks third highest since 2010–11, but end-of-season trends support stability. Challenges could arise from reporting delays inflating the figure above 85 or an unforeseen late rebound in cases among high-risk groups like those ≥65 years (266.9 per 100,000 cumulative). Week 13 data expected next week.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$1,901Date de fin
10 avr. 2026Marché ouvert
Apr 3, 2026, 12:08 PM ETResolver
0x69c47De9D...Traders' overwhelming consensus (93.5% implied probability) for an 80–85 cumulative influenza hospitalization rate per 100,000 population in Week 13 reflects the latest CDC FluSurv-NET data from the Week 12 FluView report (April 3, 2026), showing 82.7 per 100,000 amid sharply declining activity: weekly rate fell to 0.8 per 100,000, outpatient influenza-like illness (ILI) visits dropped to 2.6% below baseline, and clinical lab positivity declined to 9.8%, dominated by A(H3N2). FluSight ensemble forecasts further reductions in national hospital admissions. This season's rate ranks third highest since 2010–11, but end-of-season trends support stability. Challenges could arise from reporting delays inflating the figure above 85 or an unforeseen late rebound in cases among high-risk groups like those ≥65 years (266.9 per 100,000 cumulative). Week 13 data expected next week.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes